Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines
Guardado en:
| Autores principales: | Cardama, Georgina A., Comin, Maria J., Hornos, Leandro, Gonzalez, Nazareno, Defelipe, Lucas, Turjanski, Adrian G., Alonso, Daniel F., Gomez, Daniel E., Lorenzano Menna, Pablo |
|---|---|
| Formato: | article |
| Lenguaje: | Inglés |
| Publicado: |
Bentham Science Publishers
2014
|
| Materias: | |
| Acceso en línea: | http://www-biblio.inti.gob.ar:80/gsdl/collect/inti/index/assoc/HASH0115/144c5e4b.dir/doc.pdf |
| Aporte de: |
Ejemplares similares
-
Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines
por: Cardama, Georgina A., et al.
Publicado: (2014) -
Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines
por: Cardama, G.A., et al. -
Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines
Publicado: (2014) -
Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells
por: Cardama, Georgina A., et al.
Publicado: (2014) -
Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells
por: Cardama, Georgina A., et al.
Publicado: (2014)